/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Claus Kamby

University of Copenhagen(DK)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

141

Papers

4.8K

Citations

32

h-index

58

i10-index

Claus Kamby is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & Bladder and Urothelial Cancer Treatments. The author has an h-index of 32, co-authored 120 publications.

Research Topics

Breast Cancer Treatment Studies Cancer Treatment and Pharmacology Bladder and Urothelial Cancer Treatments Estrogen and related hormone effects Cancer Diagnosis and Treatment

Papers by this author

works

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

2008 · Cancer Treatment Reviews · 134 citations

https://doi.org/10.1016/j.ctrv.2008.09.003

Dorte Nielsen Michael Andersson Claus Kamby

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

2017 · The Lancet Oncology · 120 citations

https://doi.org/10.1016/s1470-2045(17)30715-5

Marco Colleoni Weixiu Luo Per Karlsson Jacquie Chirgwin

Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

2011 · Journal of Clinical Oncology · 35 citations

https://doi.org/10.1200/jco.2010.33.9507

Dorte Nielsen Karsten Bjerre Erik Jakobsen Søren Cold

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

2021 · Annals of Oncology · 30 citations

https://doi.org/10.1016/j.annonc.2021.07.017

Guy Jérusalem Subrina Farah Anne-Catherine Courtois Jacquie Chirgwin

Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study

2017 · Clinical and Translational Radiation Oncology · 12 citations

https://doi.org/10.1016/j.ctro.2017.01.004

Ahmed R. Eldesoky Giulio Francolini Mette S. Thomsen Esben Svitzer Yates

125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer

1999 · British Journal of Cancer · 9 citations

https://doi.org/10.1038/sj.bjc.6690565

Thomas Christensen F Engbaek J. Marqversen Soeren Nielsen

Research topics

topics

Breast Cancer Treatment Studies

Cancer Treatment and Pharmacology

Bladder and Urothelial Cancer Treatments

Estrogen and related hormone effects

Cancer Diagnosis and Treatment

Chat about Author

Papers

Chat

Click to start Chat